Beijing Bohui Innovation Biotechnology Group Co., Ltd. (SHE:300318)

SHE:300318 Revenue

Beijing Bohui Innovation Biotechnology Group had revenue of 205.66M CNY in the quarter ending June 30, 2026, with 1.66% growth. This brings the company's revenue in the last twelve months to 816.14M, up 6.16% year-over-year. In the year 2025, Beijing Bohui Innovation Biotechnology Group had annual revenue of 824.58M, down -3.18%.

• Revenue (ttm): 816.14M
• Revenue Growth: +6.16%
• P/S Ratio: 5.19
• Revenue / Employee: 376.10K
• Employees: 2,170
• Market Cap: 4.24B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	824.58M	-27.12M	-3.18%
Dec 31, 2024	851.69M	-193.73M	-18.53%
Dec 31, 2023	1.05B	249.50M	31.35%
Jan 1, 2023	795.93M	81.18M	11.36%
Jan 1, 2022	714.75M	-23.97M	-3.24%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error